List of works - Vicente Soriano

A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.

scientific article published in January 2011

A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.

scientific article published in April 2008

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

scientific article published on 12 December 2012

A new era for hepatitis C-new diagnostics tools and new weapons.

scientific article

A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients. The Hepatitis/HIV Spanish Study Group.

scientific article published on November 1997

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

scientific article published on 16 October 2013

ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients

scientific article

AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

scientific article published on 30 May 2018

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

scientific article published in November 2002

Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner

scientific article

Adaptive cell immune response against the hepatitis C virus infection

scientific article published in October 2007

Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy

scientific article published on 01 June 1997

Advances in hepatitis B therapeutics

scientific article published on 01 January 2020

Advances in the diagnosis and treatment of the infection by the hepatitis B virus

scientific article published in November 2004

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.

scientific article published on 22 December 2014

Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants

scientific article published in September 2007

An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study

scientific article

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.

scientific article published on January 2013

Analysis of pol Gene Heterogeneity, Viral Quasispecies, and Drug Resistance in Individuals Infected with Group O Strains of Human Immunodeficiency Virus Type 1 ⬇️

scientific article published on November 1, 1998

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz

scientific article

Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.

scientific article published on 04 June 2013

Antiretroviral drugs and liver injury

scientific article

Antiretroviral drugs for pre-exposure prophylaxis of HIV infection

scientific article published on January 2012

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

scientific article published on 31 May 2005

Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome

scientific article published in January 2008

Antiviral effect of raltegravir on HTLV-1 carriers

scientific article published on 29 September 2011

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

scientific article published on 23 February 2011

Are fusion inhibitors active against all HIV variants?

scientific article published in March 2004

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

scientific article

Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV

scientific article published on 01 May 1994

Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.

scientific article published on 9 July 2013

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

scientific article published in March 2011

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors

scientific article published on 01 August 1999

Association between tipranavir plasma levels and virological response in HIV-infected patients

scientific article published in March 2008

Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression

article

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

scientific article published on May 2010

Asymptomatic HIV

scientific article published on 01 November 1988

Atazanavir: the advent of a new generation of more convenient protease inhibitors

scientific article

Author's response: expert reviews: who are they for?

scientific article published in June 2012

Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C

scientific article published on 02 October 2008

Avoiding false-negative results for HTLV-II using new serological assays.

scientific article published in January 1995

Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients

scientific article published in August 2007

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

scientific article published on 28 November 2006

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens ⬇️

scientific article published on March 26, 2012

CCR5 genotype and HIV-1 infection in perinatally-exposed infants

scientific article published on 01 January 1999

CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.

scientific article published in May 1999

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy

scientific article published in February 2004

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

article

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation

scientific article published on 01 December 2005

CD4+ T-cell gain with nonnucleoside or protease inhibitors: convenience may not always be the most convenient

scientific article published in June 2004

Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

scientific article published on 01 July 2003

Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?

scientific article published in January 2006

Cancer and deep venous thrombosis

scientific article published on 01 February 1988

Cardiovascular disease risk in HIV infection and endothelial progenitor cells.

scientific article

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

scientific article published on July 2008

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

scientific article published on May 2007

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

scientific article

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

scientific article published in April 2002

Care of patients with hepatitis C and HIV co-infection

scientific article

Caution with new oral hepatitis C drugs.

scientific article

Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia

scientific article published on 5 July 2013

Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients

scientific article published in November 2011

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain

scientific article published in October 2009

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

scientific article published on 6 October 2013

Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy

scientific article published in March 2004

Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations

scientific article published in June 2005

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients

scientific article published on 29 March 2006

Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients

scientific article

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

scientific article

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir

scientific article published on June 2008

Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain

scientific article published on 6 December 2010

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

scientific article published on 01 July 2007

Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center

scientific article published on November 2005

Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation

scientific article published on May 2017

Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression

scientific article published on 15 January 2011

Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate.

scientific article published in September 1997

Chemokine receptors and HIV-2 ⬇️

scientific article published on July 15, 1997

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

scientific article published on 29 August 2006

Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less

scientific article published on March 2006

Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.

scientific article published on 10 April 2013

Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.

scientific article published in May 2000

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

scientific article published on 01 January 2011

Clinical benefit of interventions driven by therapeutic drug monitoring

scientific article published on 01 September 2005

Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).

scientific article published on January 2009

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

scientific article published on May 2004

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

scientific article published on 13 August 2012

Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients

scientific article published on 27 September 2006

Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

scientific article published in October 2006

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

scientific article published in July 2013

Combinations of nucleoside/nucleotide analogues for HIV therapy

scientific article

Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA ver

scientific article published on March 2001

Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay

scientific article published on 14 December 2011

Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon- for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial ⬇️

scientific article published on July 17, 2012

Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors

scientific article published in December 2002

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

scientific article published in April 1999

Complications in treating chronic hepatitis B in patients with HIV.

scientific article published in December 2005

Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.

scientific article published on 9 January 2012

Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons

scientific article

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.

scientific article published on January 2004

Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.

scientific article published on July 2008

Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing.

scientific article published on 8 November 2010

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

scientific article

Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

scientific article published on 01 July 2007

Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests

scientific article published on 4 February 2009

Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir

scientific article published in September 2003

Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals

scientific article published in October 2004

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.

scientific article published in June 2007

Current concepts in the management and treatment of hepatitis C in HIV-infected patients.

scientific article

Current situation of human immunodeficiency virus type 2 and Human T lymphotropic virus in Spain

scientific article published on 8 June 2010

Current trends in screening across ethnicities for hypersensitivity to abacavir

scientific article published on October 2008

Decline and changing profile of hepatitis delta among injection drug users in Spain.

scientific article published on 29 March 2017

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

scientific article published in September 2002

Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.

scientific article published on 3 March 2009

Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns ⬇️

scientific article published on March 1, 1998

Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain

scientific article published on 21 December 2010

Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms ⬇️

scientific article published on March 28, 2012

Diabetes mellitus associated with protease inhibitor use

scientific article published on 01 September 1999

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.

scientific article published on 20 June 2012

Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears.

scientific article

Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients

scientific article published in October 2006

Diarrhea related to lopinavir is most often mild and not related to plasma drug levels

scientific article published in October 2003

Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors

scientific article published in December 2002

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

scientific article published in May 2004

Differences in lopinavir plasma concentrations comparing Kaletra film coated tablets and soft gelatine capsules that result in various lipid abnormalities.

scientific article published in April 2009

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

scientific article published on 9 July 2015

Differences in the length of gag proteins among different HIV type 1 subtypes.

scientific article

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

scientific article published on June 2012

Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides

scientific article published in January 2002

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

scientific article published on 6 March 2011

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b.

scientific article published on 20 June 2012

Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations

scientific article

Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs

scientific article

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy

scientific article published in April 2005

Directly acting antivirals against hepatitis C virus

scientific article published on 07 June 2011

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

scientific article

Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.

scientific article published in August 2003

Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

scientific article

Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?

scientific article

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

scientific article published on 11 April 2013

Dolutegravir for the treatment of HIV-2 infection

scientific article published on 5 January 2015

Dolutegravir, abacavir and lamivudine as HIV therapy

scientific article published on May 2014

Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy

scientific article published on 01 November 2008

Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants

scientific article published on 14 August 2010

Drug interactions in HIV-infected patients treated for hepatitis C.

scientific article published on 10 July 2017

Drug interactions of tipranavir, a new HIV protease inhibitor

scientific article

Drug interactions with new hepatitis C oral drugs

scientific article published on 02 January 2015

Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response.

scientific article published on 23 March 2017

Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy

scientific article

Drug resistance mutations in patients infected with HIV-2 living in Spain ⬇️

scientific article published on May 10, 2011

Dual antiretroviral therapy for HIV infection

scientific article published on 16 June 2017

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.

scientific article published on 27 July 2015

Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia

scientific article published on 20 May 2010

Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.

scientific article published in September 2007

Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

scientific article

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

scientific article published in August 2005

Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia

scientific article published in October 2002

Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study

scientific article

Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma

scientific article published on 10 June 2015

Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort

scientific article

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

scientific article published on 29 May 2013

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure.

scientific article published on 11 May 2010

Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study

scientific article published in October 2007

Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group

scientific article published on 01 July 1995

Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.

scientific article published in September 2008

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.

scientific article

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

scientific article published on 13 November 2007

Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter

scientific article published in January 2002

Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.

scientific article published on April 2006

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

scientific article published on 13 October 2008

Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients

scientific article published on October 2014

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

scientific article published on 27 September 2010

Elite HIV controllers: myth or reality?

scientific article

Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.

scientific article published on 21 October 2010

Emerging antiretroviral drugs

scientific article

Emerging challenges in managing hepatitis B in HIV patients

scientific article published on 09 July 2015

Emerging drugs for hepatitis C

scientific article published in March 2008

Emerging viral infections‑-a potential threat for blood supply in the 21st century.

scientific article published on October 2012

Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

scientific article published on October 2012

Enfuvirtide is active against HIV type 1 group O.

scientific article published in June 2005

Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

scientific article published in June 2004

Enhanced diagnostic efficiency of the polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2

scientific article published on 01 August 1994

Enhancement of HIV antigen detection after acid dissociation of immune complexes is associated with loss of specificity

scientific article published on 01 January 1995

Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group

scientific article

Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group.

scientific article published in December 1996

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

scientific article published on 12 January 2008

Escape mutations in HIV infection and its impact on CD8+ T cell responses

scientific article published on August 2007

Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.

scientific article

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

scientific article published in January 2010

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

scientific article published in February 2008

European guideline for the management of hepatitis B and C virus infections, 2010.

scientific article published in October 2010

European guidelines on the clinical management of HIV-1 tropism testing

scientific article published on 21 March 2011

European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.

scientific article published on 24 February 2014

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

scientific article published on April 1, 2011

Evaluation of a new fluorescence immunoassay for CD4+ and CD8+ T cell counts in clinical samples

scientific article published on 01 January 1994

Evaluation of a new saliva collection device for HIV antibody screening purposes

scientific article published on 01 January 1994

Evaluation of different supplementary assays for the confirmation of HIV-1 and HIV-2 infections.

scientific article published in January 1994

Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

scientific article

Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.

scientific article published in May 2008

Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses

scientific article published on 20 December 2006

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.

scientific article

Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.

scientific article

Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.

scientific article published on 27 September 2004

Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

scientific article published in March 2008

Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.

scientific article published on March 1997

Evidence of Nef Truncation in Human Immunodeficiency Virus Type 2 Infection ⬇️

scientific article published on January 1, 1998

Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients.

scientific article published in January 2007

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

scientific article published in September 2004

Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years

scientific article published on 01 September 2010

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

scientific article published in September 2002

Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients

scientific article published on September 2015

Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

scientific article published on August 2002

Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.

scientific article published on 24 August 2005

Faldaprevir and deleobuvir for HCV genotype 1 infection.

scientific article published on August 2013

Fatal varicella hepatitis in a patient with AIDS

scientific article published on 01 July 1992

First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome

scientific article published on 01 September 2009

First-line therapy and mitochondrial damage: different nucleosides, different findings

scientific article

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program

scientific article published on 9 January 2009

Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain

scientific article published on 01 January 2009

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

scientific article

From respiratory sensitization to food allergy: Anaphylactic reaction after ingestion of mushrooms (Agaricus bisporus).

scientific article published on 24 February 2015

Gene Editing for HIV Cure at the Edge

scientific article published on 01 January 2019

Gene therapy for HIV infection.

scientific article

Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS.

scientific article published in July 1997

Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV type 1 Non-B subtypes

scientific article

Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression

scientific article published on 09 December 2006

Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools.

scientific article

Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients

scientific article published on 11 January 2013

Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

scientific article published on 01 January 2007

Genetic mechanisms of resistance to NRTI and NNRTI.

scientific article

Genetic mechanisms of resistance to protease inhibitors and entry inhibitors

scientific article

Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction

scientific article

Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

scientific article published on 14 January 2014

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

scientific article

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients. ⬇️

scientific article

Gynecomastia in HIV-infected patients receiving antiretroviral therapy

scientific article published on 01 September 2003

HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

article

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals

scientific article published in May 2011

HIV Gag-specific immune response mediated by double negative (CD3(+)CD4(-)CD8(-)) T cells in HIV-exposed seronegative individuals

scientific article published on 21 November 2012

HIV and HCV coinfection

scientific article published in May 2006

HIV and Liver Disease ⬇️

scientific article published on July 3, 2012

HIV co-infection in HTLV-1 carriers in Spain

scientific article published on 15 April 2019

HIV entry inhibitors: mechanisms of action and resistance pathways

scientific article

HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

scientific article published on June 2013

HIV protease inhibitors: recent clinical trials and recommendations on use.

scientific article published on July 2009

HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality

scientific article published on 01 September 2008

HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

article

HIV type 2 epidemic in Spain: challenges and missing opportunities.

scientific article

HIV-1 causing AIDS and death in a seronegative individual

scientific article published on 01 January 1994

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines

scientific article published in January 2009

HIV-1 infection in persistently HIV-1-seronegative individuals: more reasons for HIV RNA screening

scientific article published on 01 March 2008

HIV-1 subtype J recombinant viruses in Spain

scientific article published on 01 May 2002

HIV-2 and HTLV-1 infections in Spain, a non-endemic region

scientific article published on July 2014

HIV-2 in Spain.

scientific article published in October 1989

HIV-2 infection in high-risk individuals with indeterminate HIV-1 western blot analysis: a serologic surveillance.

scientific article published in January 1992

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

scientific article published in February 2004

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

scientific article published on 30 April 2014

HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe

scientific article

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.

scientific article published on May 2013

HTLV infection among foreign pregnant women living in Spain

scientific article published on 22 July 2011

HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.

scientific article published on 6 September 2005

HTLV infection in HCV-antibody positive patients in Spain

scientific article published on 7 March 2017

HTLV testing of solid organ transplant donors

scientific article published on 08 October 2019

HTLV-1 infection and disease in Spain

scientific article published on May 2017

HTLV-1 infection in solid organ transplant donors and recipients in Spain

scientific article published on 09 August 2019

HTLV-I and HTLV-II infections in Spain.

scientific article published in January 1993

HTLV-I/II infection among immigrants to Spain.

scientific article

HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)

scientific article published on 23 February 2016

Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin

scientific article published in September 2005

Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis

scientific article published on 4 June 2015

Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C.

scientific article published on 23 December 2009

Hepatitis A Outbreaks in European Homosexual Men.

scientific article published on 23 May 2017

Hepatitis B in HIV patients: what is the current treatment and what are the challenges?

scientific article published in March 2009

Hepatitis B in HIV-infected patients

scientific article published on 08 July 2013

Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs

scientific article published on 14 September 2007

Hepatitis B virus escape mutants induced by antiviral therapy

scientific article published on 24 January 2008

Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir

scientific article published on 8 May 2008

Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients

scientific article

Hepatitis B virus infection despite receiving lamivudine in one HIV-infected person

scientific article

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain

scientific article published on 21 January 2013

Hepatitis B: treatment strategies and resistance

Hepatitis C cure with antiviral therapy--benefits beyond the liver

scientific article published on 25 June 2015

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

scientific article

Hepatitis C therapy with HCV NS5B polymerase inhibitors

scientific article published on 27 April 2013

Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver

scientific article published on 22 October 2012

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

scientific article published in January 2000

Hepatitis C viremia in HIV/HCV-coinfected patients: lower levels in presence of chronic hepatitis B.

scientific article published in March 2005

Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients

scientific article published on 2 December 2004

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.

scientific article published on April 2004

Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy

scientific article published on July 2008

Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression

scientific article published on April 2009

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

scientific article published on 21 September 2015

Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves

scientific article published on 16 July 2013

Hepatitis C virus resistance to the new direct-acting antivirals

scientific article

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

scientific article published on September 2012

Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.

scientific article published on August 2004

Hepatitis Delta Could Be More Frequent than Previously Thought

scientific article published on 01 January 2018

Hepatitis Delta Enters a New Therapeutic Era.

scientific article published on 7 February 2018

Hepatitis Delta Estimates in the United States Revisited

scientific article published on 01 October 2019

Hepatitis delta and HIV infection

scientific article published on 24 January 2017

Hepatitis delta in HIV-infected individuals in Europe.

scientific article

Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients

scientific article published on 14 March 2014

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

scientific article published on 01 January 2001

Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome

scientific article published in November 2004

Hepatotoxicity after introduction of highly active antiretroviral therapy

scientific article published on 01 July 1998

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

scientific article

Heterogeneous nature of HIV-1 recombinants spreading in Spain

scientific article published on 01 March 2005

High alcohol intake and slow progression to AIDS.

scientific article published on October 1996

High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain

scientific article published on 01 January 1994

High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid

scientific article

High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor

scientific article published in January 2010

High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain. Hepatitis HIV Spanish Study Group.

scientific article

High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.

scientific article published in January 2006

High rate of resistance to antiretroviral drugs among HIV-infected prison inmates

scientific article

High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

scientific article published on 28 April 2010

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.

scientific article

Higher antiviral activity of antiretroviral regimens including protease inhibitors.

scientific article published in May 1999

Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations

scientific article

Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

scientific article published in April 2006

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure ⬇️

scientific article published on August 1, 2012

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France

scientific article

Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C.

scientific article published in January 1998

Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies

scientific article published on 01 May 1990

Hospital-based surveillance for HTLV-1/2 infections in Spain.

scientific article published in September 2007

Host factors involved in low susceptibility to HIV infection.

scientific article published on January 2011

Host genetics.

scientific article

Hot News

scholarly article

Hot News: Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure

scientific article published on 11 October 2017

Hot News: Hepatitis B Gene Therapy Coming to Age

article

How effective is HAART in HCV and HIV coinfection?

scientific article published on 01 October 2004

Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.

scientific article published on 26 September 2007

Human T-cell lymphotropic virus infection in pregnant women in Spain.

scientific article published in October 1997

Human herpesvirus 6 in Spain: seroprevalence in blood donors and patients with lymphoproliferative disorders or HIV infection

scientific article published on 01 January 1991

Human immunodeficiency virus and liver disease: conference proceedings

scientific article published on 01 March 2010

Human immunodeficiency virus infection and viral hepatitis

scientific article published on 5 October 2011

Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal.

scientific article published in May 2003

Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load

article

Human immunodeficiency virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update

scientific article published on 9 April 2009

Human immunodeficiency virus type 2 infection in Spain. The HIV-2 Spanish Study Group

scientific article published on January 1999

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

scientific article

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

scientific article

Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation

scientific article published on 18 May 2007

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy

scientific article published on 01 January 2000

Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy

scientific article published in November 2003

Hypoglycemia in a diabetic patient during hepatitis C therapy.

scientific article

IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.

scientific article published on September 2015

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians

scientific article

IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.

scientific article published on 2 February 2016

IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin

scientific article published on May 2011

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.

scientific article published on 20 December 2012

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection

scientific article published on 9 December 2015

Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library

scientific article

Idiopathic CD4+ T-lymphocytopenia

scientific article published on 01 September 1992

Immediate hypersensitivity to heparins: a cross-reactivity study

scientific article published on 01 January 2014

Immunizations in HIV-infected adults

scientific article published on July 2007

Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine

scientific article

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

scientific article

Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients

scientific article published in September 2006

Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir

scientific article published in September 2002

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

scientific article

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

scientific article published on February 2012

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

scientific article published in May 2011

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.

scientific article published on 15 February 2017

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia.

scientific article published on 4 November 2010

Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years

scientific article

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

scientific article published on 27 September 2011

Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.

scientific article published on 6 December 2007

Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients

scientific article published on 01 September 2006

Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.

scientific article published in July 2011

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients.

scientific article

Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

scientific article published on 2 October 2007

Impact of chronic hepatitis C on HIV-1 disease progression

scientific article published on 01 May 2004

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

scientific article

Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens

scientific article published in January 2004

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

scientific article published in September 2005

Impact of ethnicity and HIV type 1 subtype on response to first-line antiretroviral therapy

scientific article published on 01 July 2007

Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes

scientific article published in November 2004

Impact of hepatitis C virus (HCV) on morbidity and mortality rates among HIV-infected patients

scientific article published in August 2003

Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

scientific article published on August 2005

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

scientific article published on 25 October 2011

Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.

scientific article published in January 2005

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

scientific article published in April 2010

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

scientific article published on May 2009

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

scientific article published on 8 December 2003

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

article

Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine

scientific article

Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

scientific article published on November 2008

Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain

scientific article published in June 2008

Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure

scientific article published in June 2003

Indinavir-induced thrombocytopenia

scientific article

Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.

scientific article published in November 2000

Infection by HIV-2, HTLV and new human retroviruses in Spain ⬇️

scientific article published on May 11, 2011

Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain

scientific article

Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.

scientific article published in September 2002

Infections due to human immunodeficiency virus type 2 and human T-lymphotropic viruses in Spain

scientific article published on 6 September 2013

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects

scientific article published on 31 March 2005

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus

scientific article published in May 2007

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.

scientific article published on September 2013

Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients

scientific article published on April 2005

Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection

scientific article published in October 2010

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

scientific article

Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients

scientific article published on 21 November 2006

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

scientific article published in June 2011

Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C

scientific article published on 20 February 2007

Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

scientific article published in January 2008

Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

scientific article published on June 2006

Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.

scientific article published on 5 June 2009

Insufficiencies of the new WHO western blot criteria in the diagnosis of HIV-1 and HIV-2 infections

scientific article published on 01 January 1992

Integrase inhibitors.

scientific article

Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection

scientific article published on 9 December 2009

Intensification of antiretroviral therapy.

scientific article

Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients.

scientific article published in October 2000

Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

scientific article published on 16 October 2014

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.

scientific article published on March 2013

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

scientific article published in January 2011

Intrapatient and Interpatient Pharmacokinetic Variability of Raltegravir in the Clinical Setting

Introduction of HIV drug-resistance testing in clinical practice

scientific article published on 01 June 1999

Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands

scientific article published in April 2007

Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.

scientific article published on December 2014

Is HIV still a special population for the treatment of hepatitis C?

scientific article published on July 2016

Is Ribavirin Teratogenic in Humans? No Evidence So Far.

scientific article published on 14 September 2017

Is natural conception a valid option for HIV-serodiscordant couples?

scientific article published on 19 July 2007

Is there a role for indinavir twice-daily in clinical practice?

scientific article published on 01 March 2000

Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?

scientific article published on 01 July 2000

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

scientific article published on 01 December 2005

Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?

scientific article published in April 2003

Jérôme Lejeune passed away 25 years ago

scientific article published on 06 June 2019

Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual

scientific article published on 01 April 1992

Keeping alive enterprises while embracing unprecedented COVID-19 restrictions

scientific article published on 01 January 2020

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

scientific article

LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression

scientific article

Lack of 'occult' hepatitis B virus infection in HIV-infected patients.

scientific article published in October 2002

Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses

scientific article published in October 2007

Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients

scientific article published on 01 March 1998

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.

scientific article published on 27 April 2009

Lack of significant cross-reactivity for HIV-2 immunoblots in HIV-1-infected patients

scientific article published on 01 March 2009

Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V-->I) of the reverse transcriptase

scientific article published on May 2003

Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

article

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study) ⬇️

scientific article published on April 24, 2011

Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy

scientific article published in May 2002

Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

article

Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons

scientific article published in September 2002

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

scientific article published in March 2008

Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity

scientific article

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

scientific article published on 22 January 2008

Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients

scientific article published on 5 November 2014

Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy.

scientific article published on 5 November 2013

Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases

scientific article published in June 2007

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

scientific article published in July 2002

Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.

scientific article published on April 2013

Liver toxicity caused by nevirapine

scientific article published in January 2002

Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?

scientific article

Long-acting antiretroviral therapy

scientific article published on 01 August 2020

Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.

scientific article published on December 2004

Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors

scientific article published on 02 March 2011

Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.

scientific article

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C.

scientific article published on 8 August 2014

Longer Life Expectancy but still Accelerating Aging in HIV Patients under Antiretroviral Therapy

scientific article published on 01 January 2018

Longitudinal assessment of interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy

scientific article published on 01 December 2011

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

scientific article published on 30 July 2013

Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.

scientific article

Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients

scientific article published in April 2013

Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine.

scientific article published in December 2001

Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.

scientific article published on 11 June 2010

Management and therapy of chronic hepatitis C in HIV.

scientific article

Management and treatment of chronic hepatitis B in HIV-positive patients

scientific article published on 10 April 2014

Management and treatment of chronic hepatitis C in HIV patients

scientific article published on May 2012

Management of chronic hepatitis B and C in HIV-coinfected patients

scientific article published on 23 March 2006

Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.

scientific article published on January 2004

Management of chronic hepatitis C virus infection in HIV-infected patients

scientific article published on July 2008

Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.

scientific article

Management of hepatitis B virus co-infection on and off antiretroviral therapy

scientific article published on May 2008

Management of hepatitis C in HIV and/or HBV co-infected patients.

scientific article published on August 2012

Management of metabolic complications and cardiovascular risk in HIV-infected patients

scientific article published on October 2010

Management of patients co-infected with hepatitis B virus and HIV.

scientific article

Measurement of Human Immunodeficiency Virus Type 1 Plasma Virus Load Based on Reverse Transcriptase (RT) Activity: Evidence of Variabilities in Levels of Virion‐Associated RT ⬇️

scientific article published on May 1, 1998

Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C.

scientific article published in December 2007

Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir

scientific article published in March 2012

Mechanisms of resistance to antiretroviral drugs--clinical implications.

scientific article

Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma

scientific article

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

scientific article published in March 2007

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

scientific article published in November 2010

Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain

scientific article published in December 2006

Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

scientific article

Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

scientific article

Molecular evidence of homosexual transmission of HIV type 2 in Spain.

scientific article published in March 2001

Monthly cyclic therapy in heavily pretreated HIV-infected patients.

scientific article

Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus.

scientific article published in November 2001

Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.

scientific article published on 25 April 2005

Multifocal bone tuberculosis in one AIDS patient ⬇️

scientific article published on August 1, 1992

Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity.

scientific article published on 22 July 2009

Mycosis fungoides and Sezary syndrome are not associated with HTLV‐I infection: an international study ⬇️

scientific article published on September 1, 1997

Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients

scientific article published in January 2011

Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure

scientific article

Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.

scientific article published in November 2006

Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

scientific article published in November 2001

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.

scientific article published on 25 August 2017

Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations

scientific article

Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial

article

New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.

scientific article

New antivirals for the treatment of chronic hepatitis B.

scientific article

New findings on transcription regulation across different HIV-1 subtypes.

scientific article

New hepatitis C therapies for special patient populations

scientific article

New hopes for HIV and HCV coinfection in 2004.

scientific article published in July 2004

New human retrovirus

scientific article

New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients

scientific article published on 19 January 2010

New paradigms in the management of HIV and hepatitis C virus coinfection

scientific article

New therapeutic strategies for raltegravir

scientific article published on 16 December 2009

New therapies for hepatitis C virus infection

scientific article published on 01 February 2009

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

article

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

scientific article published on 7 June 2012

No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors

scientific article published in September 2008

Non-Human Cancers in AIDS Patients

scientific article published in October 2015

Noncirrhotic portal hypertension in HIV infection

scientific article published on February 2011

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.

scientific article published in May 2010

Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy

scientific article

Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of ant

scientific article published on 31 May 2011

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

scientific article published on August 2007

Nucleoside/nucleotide backbones for the treatment of HIV infection

scientific article

Obituary: HIV/AIDS researcher Mark Wainberg passed away

scientific article published on 30 June 2017

Occult hepatitis B and HIV infection

scientific article published on 01 November 2019

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

scientific article published in December 2008

Optimal use of maraviroc in clinical practice

scientific article

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc ⬇️

scientific article published on March 19, 2010

Outbreak of syphilis, but not of acute hepatitis C, among HIV-infected homosexual men in Madrid

article

Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.

scientific article published in January 2009

Overview of the pharmacogenetics of HIV therapy.

scientific article

PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.

scientific article published on October 2014

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

scientific article published in March 2005

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

scientific article published in May 2003

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.

scientific article published on 28 March 2013

Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients

article

Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters

scientific article published on July 2008

Performance of drug resistance assays in testing HIV-1 non-B subtypes.

scientific article published in April 2003

Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants

scientific article published on 2 July 2008

Pharmacogenetics in HIV therapy.

scientific article

Pharmacogenetics of antiretroviral therapy

scientific article

Pharmacogenetics of hepatitis C.

scientific article published on 22 December 2011

Pharmacogenetics of tenofovir treatment

scientific article published on October 2009

Pharmacokinetics of new oral hepatitis C antiviral drugs ⬇️

scientific article published on October 25, 2012

Pharmacokinetics, interactions and mechanism of action of maraviroc

scientific article

Phase I study of mitonafide in solid tumors

scientific article published on August 1, 1992

Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy

scientific article

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

scientific article

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

scientific article published on 21 December 2011

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

scientific article

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1

scientific article

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.

scientific article

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

scientific article

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

scientific article published on 15 December 2011

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

scientific article published on 13 December 2011

Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient

scientific article published in March 2004

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

scientific article

Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients

scientific article published in December 2005

Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus

scientific article published on 11 February 2019

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

scientific article published on 5 January 2010

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

scientific article (publication date: June 2009)

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

scientific article published on 21 February 2006

Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations

scientific article

Predictors of virological response to atazanavir in protease inhibitor-experienced patients

scientific article published in July 2004

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.

scientific article published in April 2010

Preexposure prophylaxis in the prevention of HIV infection

scientific article

Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.

scientific article published in January 2007

Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain

article

Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients.

scientific article published in January 2001

Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance

scientific article

Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.

scientific article published on 8 May 2018

Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up.

scientific article published in July 2012

Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients

scientific article published in March 2007

Prevalence of G333D/E in naive and pretreated HIV-infected patients

scientific article published in August 2002

Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain.

scientific article published in December 2004

Prevalence of HTLV infection in pregnant women in Spain

scientific article published on October 2000

Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey ⬇️

scientific article published on August 1, 2010

Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

scientific article

Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

scientific article published on 27 February 2007

Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.

scientific article published on 13 June 2008

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

scientific article published on 23 July 2007

Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues

scientific article

Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure

scientific article published on 01 July 2000

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

scientific article published on 15 August 2005

Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors

scientific article published on 3 October 2007

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

article

Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group ⬇️

scientific article published on July 1, 1995

Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.

scientific article

Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain.

scientific article published in August 1995

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

scientific article

Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir

scientific article

Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

scientific article published on 01 April 2006

Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.

scientific article published on 21 February 2012

Prevention and management of treatment failure to new oral hepatitis C drugs.

scientific article published on 5 May 2016

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

scientific article published on 01 September 2000

Primary lymphoma of the central nervous system and HTLV-I infection

scientific article published on 01 January 2002

Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

scientific article

Prioritization of new oral hepatitis C therapies for HIV patients

Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.

scientific article published on May 2008

Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies

scientific article published on 25 June 2014

Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).

scientific article published on 8 November 2006

RNA viruses at the forefront of human infections - HIV, hepatitis C, and now Ebola

scientific article published in October 2014

Raltegravir and etravirine are active against HIV type 1 group O.

scientific article published in February 2009

Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O

scientific article published in 2003

Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.

scientific article

Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor

scientific article published on January 2003

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals ⬇️

scientific article published on 01 January 2019

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.

scientific article published on 13 August 2015

Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C Virus coinfected patients with prior nonresponse or relapse

scientific article published in March 2010

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

scientific article published on 24 June 2016

Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients

scientific article published on November 2009

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

scientific article published on December 2006

Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain

scientific article published on October 2002

Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy

scientific article

Reactivation of Hepatitis B in HIV Patients Treated for Hepatitis C.

scientific article

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

article

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

article

Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS

article

Recombinant human immunodeficiency viruses type 1 circulating in Spain.

scientific article published in March 2000

Recomendaciones españolas sobre el uso adecuado de enfuvirtida

scientific article published on 01 February 2007

Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.

scientific article published in December 2006

Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activity

scientific article

Regression of Invasive AIDS‐Related Kaposi's Sarcoma Following Antiretroviral Therapy

article

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

scientific article published in November 2006

Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.

scientific article

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

scientific article published on 02 September 2016

Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections.

scientific article

Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms

scientific article published on 08 October 2008

Renal toxicity associated with tenofovir use.

scientific article published on July 2010

Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?

scientific article published in July 2003

Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy

scientific article published in April 2003

Reply to Pascual Pareja et al

scientific article published in 2009

Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.

scientific article

Reproductive options for HIV-serodiscordant couples.

scientific article published on July 2006

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience

scientific article published on 23 March 2011

Resistance in hepatitis B virus

scientific article published in May 2008

Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations.

scientific article published in September 2002

Resistance to HIV protease inhibitors: mechanisms and clinical consequences

scientific article published in August 2004

Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes

scientific article

Resistance to entry inhibitors

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

scientific article published on 29 September 2005

Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

scientific article

Retreatment for 24 vs 48 weeks with interferon-alpha2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone.

scientific article published in November 2000

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

scientific article

Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

scientific article published on May 2012

Risk for immune-mediated liver reactions by nevirapine revisited.

scientific article published on April 2008

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

scientific article published in November 2005

Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients

article

Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients

scientific article published in March 2005

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

scientific article published on 01 May 2000

Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions

scientific article

Role of atazanavir in the treatment of HIV infection

scientific article published on February 2009

Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.

scientific article published in September 2003

Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy

scientific article published in May 2002

Role of tenofovir in HIV and hepatitis C virus coinfection

scientific article published in June 2008

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

scientific article published in August 2007

SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals

scientific article published on 01 May 2002

SENV infection in HIV-positive patients: prevalence, subtype characterization, and impact on HIV disease progression

scientific article

SOLAR-2: the sun also rises for cirrhotics.

scientific article

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study

scientific article

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

scientific article published in March 2010

Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir ⬇️

scientific article published on 01 December 1997

Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience

scientific article published on 17 March 2016

Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families

scientific article published in July 2002

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

scientific article published on 3 June 2013

Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana.

scientific article published in January 2019

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

scientific article

Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

scientific article published on 13 March 2013

Sequence Note: Genetic Analysis of Human Immunodeficiency Virus Type 2 Strains from Spain ⬇️

scientific article published on January 1, 1998

Serological markers of human immunodeficiency virus infection in African patients with AIDS: are they different from markers found in patients from other countries?

scientific article

Seroprevalence of HTLV infection among immigrant pregnant women in the Mediterranean coast of Spain.

scientific article

Seroprevalence of HTLV infection in Spain among immigrant pregnant women.

scientific article published on 6 June 2011

Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

scientific article published on June 2009

Seroreversion in patients with end-stage HIV infection.

scientific article published in January 1994

Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART.

scientific article

Seroreversion of hepatitis C virus (HCV) antibodies in an HIV-infected patient despite continuous HCV replication

scientific article published on June 2009

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

scientific article published on 01 June 2006

Severe myopathy in an injection drug user coinfected with human immunodeficiency virus type 1 and human T cell leukemia virus type II.

scientific article published in August 1994

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients

scientific article published on 5 May 2008

Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.

scientific article published on 23 October 2015

Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy

scientific article published on 23 March 2011

Short article: Hepatitis delta in patients with resolved hepatitis B virus infection

scientific article published on 01 September 2018

Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells

scientific article published on 21 September 2011

Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?

scientific article published on 23 March 2012

Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses

scientific article

Short communication: benefits in the lipid profile after substitution of abacavir for Stavudine: a 48-week prospective study

scientific article published in December 2004

Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients

scientific article published in March 2003

Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection

scientific article

Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions

scientific article

Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals

scientific article published in December 2009

Should HIV Patients be concerned about Occult Hepatitis B?

scientific article published on 01 January 2018

Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.

scientific article published in January 1994

Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk.

scientific article published in March 1997

Significance of positive polymerase chain reaction results in HIV-seronegative individuals

scientific article published on 01 January 1992

Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain

scientific article published on 01 April 1990

Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trial

scientific article published on July 2010

Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.

scientific article

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

scientific article published in January 2005

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

scientific article published on 01 September 1999

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy

scientific article published on 12 August 2011

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

scientific article

Spanish consensus conference on drug resistance testing in clinical practice. HIV drug resistance Spanish panel.

scientific article

Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.

scientific article published on June 2014

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

scientific article published on November 2008

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

scientific article published on 27 March 2013

Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.

scientific article published on September 2008

Strategic use of lamivudine in the management of chronic hepatitis B.

scientific article published on 17 September 2013

Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir

scientific article published on 10 March 2006

Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola

scientific article

Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors

scientific article published on 01 July 2006

Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption

scientific article published on 01 August 2005

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells

scientific article published on 01 June 2008

Survival of HIV-infected patients with compensated liver cirrhosis

article

Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide

scientific article published on 29 December 2006

Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy

scientific article published on 7 February 2006

Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients

scientific article published on January 2006

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

scientific article published on 22 November 2013

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy.

scientific article

Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring

scientific article published in June 2008

Synthetic peptide immunoassay for diagnosis of HIV 2 infection

scientific article published on 01 January 1989

Synthetic peptide immunoassay in diagnosis of primary HIV infection.

scientific article

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

scientific article published on April 2007

T regulatory cells and HIV infection.

scientific article published on January 2007

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

scientific article published on 9 February 2015

Telbivudine: a new option for the treatment of chronic hepatitis B.

scientific article published on May 2007

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.

scientific article

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption.

scientific article published on 11 May 2010

Tenofovir for Hepatitis Delta

scientific article published on 28 July 2015

Tenofovir-related nephrotoxicity in HIV-infected patients

scientific article published in April 2004

Tests for HIV in lupus

scientific article published on 01 September 1994

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

article

The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support ⬇️

scientific article published on 01 May 1998

The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring

scientific article published in April 2010

The challenge of the new H1N1 influenza A

scientific article

The changing epidemiology of liver disease in HIV patients.

scientific article published on January 2013

The changing face of hepatitis C in the new era of direct-acting antivirals.

scientific article published on 9 November 2012

The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load

scientific article published on 01 May 1998

The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

scientific article published on 01 November 2011

The global spread of HIV-1 subtype B epidemic

scientific article

The implications of antiviral drugs with activity against hepatitis B virus and HIV.

scientific article published on December 2007

The role of CD8+ T-cell response in HIV infection.

scientific article published in April 2004

The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.

scientific article

The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.

scientific article published on 24 February 2009

The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women.

scientific article published in January 2005

Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples.

scientific article published in January 1993

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

article

Tolerability of abacavir in the clinical setting

scientific article published on 01 November 2000

Tolerance of didanosine as enteric-coated capsules versus buffered tablets.

scientific article published in June 2004

Towards hepatitis C eradication from the HIV-infected population

scientific article published on 15 February 2014

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

scientific article published on 20 May 2009

Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor

scientific article published on 01 June 2003

Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis

scientific article published on January 2017

Treatment and prevention of HIV infection with long-acting antiretrovirals

scientific article published on 29 March 2018

Treatment failure with new hepatitis C drugs

scientific article published on 14 January 2012

Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future

scientific article published on 29 October 2003

Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis

scientific article published on 2 March 2007

Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis

scientific article

Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.

scientific article published in December 2003

Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates

scientific article

Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?

scientific article published in March 2003

Treatment of hepatitis C in HIV patients in the new DAA era.

scientific article published on 23 May 2014

Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.

scientific article published on 10 September 2012

Treatment of hepatitis C with new fixed dose combinations

scientific article published on 23 June 2017

Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

scientific article published on 01 November 2019

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study

scientific article published on 9 March 2016

Treatment response and drug resistance in patients infected with HIV type 1 group O viruses

scientific article published in July 2005

Treatment with Raltegravir, a retroviral integrase inhibitor, in patients infected with HTLV-1.

scientific article published on 6 June 2011

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

scientific article

Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain ⬇️

scientific article published on March 23, 2012

Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

scientific article published on 3 May 2013

Tropism, Coreceptor Use, and Phylogenetic Analysis of Both the V3 Loop and the Protease Gene of Three Novel HIV-1 Group O Isolates ⬇️

scientific article published on August 15, 1998

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.

scientific article published in January 2008

Update of the DHHS antiretroviral treatment guidelines

scientific article published in April 2014

Update on HIV/HCV coinfection.

scientific article published on September 2013

Update on the treatment of chronic hepatitis C in HIV-infected patients

scientific article published on April 2007

Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.

scientific article published on November 2008

Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.

scientific article published on 13 July 2009

Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.

scientific article published on 9 June 2010

Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting.

scientific article

Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C.

scientific article published on 17 October 2008

Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards

scientific article

Variability in the P6gag domains of HIV-1 involved in viral budding

scientific article published on 01 February 2006

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes

scientific article published on 9 December 2011

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.

scientific article published on November 2013

Very late HCV relapse following triple therapy for hepatitis C.

scientific article published on 17 February 2014

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.

scientific article published on 27 June 2013

Viral hepatitis and HIV co-infection

scientific article

Viral hepatitis: Treating hepatitis C in injection drug users

scientific article published on 3 September 2013

Viral resistance and genetic barrier of atazanavir

scientific article published in December 2008

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment

scientific article published in February 2002

Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.

scientific article

Virus load and cytolitic responses in human immunodeficiency virus infection: what is cause and what is effect

scientific article published in September 2003

Visceral leishmaniasis in patients infected with the human immunodeficiency virus ⬇️

scientific article published on December 1, 1997

Weight loss in HIV-infected patients

scientific article published in October 2002

What dual protease inhibitor combination for salvage therapies?

scientific article published on 01 October 1999

When and how to use maraviroc in HIV-infected patients

scientific article published in November 2009

Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

scientific article (publication date: July 2008)

Why such excess of mortality for COVID-19 in Spain?

scientific article published on 01 January 2020

X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

scientific article published on July 2014

[Acute hepatitis B in a previously vaccinated patient infected by the human immunodeficiency virus]

scientific article published on 01 October 2001

[Antiretroviral therapy in HIV infection: how long its efficacy?]

scientific article published on 01 February 2006

[Current status of HIV-2 and HTLV-1/2 infection in Spain: lights and shades].

scientific article published in April 2005

[Diagnosis of HIV-1 non-B subtypes and HIV-2]

scientific article published on 01 November 2008

[HIV-2 and HTLV-1/2 infections in Spain].

scientific article published on 27 June 2009

[HIV-2 and HTLV-I/II infections in Spain].

scientific article published in March 2004

[HIV-2 infection and human lymphotropic type 1 and type 2 virus in Spain].

scientific article published in June 2007

[Healthcare resources restrictions and human immunodeficiency virus infection]

scientific article published on 26 March 2013

[Hepatitis B in 2008]

scientific article published on 01 May 2008

[Hepatitis E: an emerging viral disease]

scientific article published on 20 March 2014

[Infections due to HIV-2 and HTLV-1/2 in Spain].

scientific article published in October 2006

[Intensification of antiretroviral treatment]

scientific article published on 01 February 2000

[Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy]

scientific article published on 08 April 2009

[Regulation of transcription in different HIV-1 subtypes]

scientific article published on 01 March 2005

[Reproductive advice in HIV-discordant couples]

scientific article published on 01 June 2007

[Resistance to integrase inhibitors].

scientific article

[Simplification of the antiretroviral regimens. A need to guarantee the long-term control of HIV infection]

scientific article published on 01 April 2004

[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program]

scientific article published on 01 September 2000

[XMRV, a new human retrovirus for disease]

scientific article published on 05 March 2011

List of works by Vicente Soriano

A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.

A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

A new era for hepatitis C-new diagnostics tools and new weapons.

A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients. The Hepatitis/HIV Spanish Study Group.

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients

AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner

Adaptive cell immune response against the hepatitis C virus infection

Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy

Advances in hepatitis B therapeutics

Advances in the diagnosis and treatment of the infection by the hepatitis B virus

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.

Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants

An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.

Analysis of pol Gene Heterogeneity, Viral Quasispecies, and Drug Resistance in Individuals Infected with Group O Strains of Human Immunodeficiency Virus Type 1 ⬇️

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz

Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.

Antiretroviral drugs and liver injury

Antiretroviral drugs for pre-exposure prophylaxis of HIV infection

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome

Antiviral effect of raltegravir on HTLV-1 carriers

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

Are fusion inhibitors active against all HIV variants?

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV

Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors

Association between tipranavir plasma levels and virological response in HIV-infected patients

Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

Asymptomatic HIV

Atazanavir: the advent of a new generation of more convenient protease inhibitors

Author's response: expert reviews: who are they for?

Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C

Avoiding false-negative results for HTLV-II using new serological assays.

Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens ⬇️

CCR5 genotype and HIV-1 infection in perinatally-exposed infants

CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation

CD4+ T-cell gain with nonnucleoside or protease inhibitors: convenience may not always be the most convenient

Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?

Cancer and deep venous thrombosis

Cardiovascular disease risk in HIV infection and endothelial progenitor cells.

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

Care of patients with hepatitis C and HIV co-infection

Caution with new oral hepatitis C drugs.

Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia

Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy

Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients

Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir

Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center

Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation

Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression

Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate.

Chemokine receptors and HIV-2 ⬇️

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less